External Selection Committee (ESC)
The ESC serves the key role of reviewing project applications submitted to the Technology Development Program and making funding recommendations. The committee is comprised of twelve members who represent broad clinical, science, finance, business development and commercialization backgrounds. Collectively they review, score, rank, and make recommendations as to which projects the Center should fund. The Committee convenes twice a year as the final internal selection process step of each funding cycle.
ESC Members
John M Rice, PhD (Chair)
Director, Life Sciences
CincyTech LLC
Managing Partner,
Triathlon Medical Ventures
513-703-1404 [email protected]
View Bio
Steven Girouard, PhD
President and CEO
Securus Medical Group
216-658-5478 [email protected]
View Bio
John Harrington, PhD
Executive Vice President and Chief Scientific Officer
Athersys, Inc.
216-431-9900 [email protected]
View Bio
Peter Kleinhenz, MBA
Managing Director
Venture Group
CID Capital
614-222-8185 [email protected]
View Bio
Timothy J. Miller, PhD
President & CEO
Abeona Therapeutics, Inc.
[email protected]
abeonatherapeutics.com
Kenneth L Morand, PhD
New Business Creation
The Procter and Gamble Co.
513-780-7943 [email protected]
View Bio
Josh C Nickols PhD
Executive in Residence,
Life Sciences
CincyTech USA
(615) 554-7000 [email protected]
View Bio
Joseph Pastore, PhD
We mourn the passing of our colleague and friend.
Senior Vice President, Clinical Product Development
Juventas Therapeutics
View Bio
Matthew Pollman, MD
Cardiologist,
Medical Industry Executive,
Entrepreneur
415-606-3909 [email protected]
View Bio
Roy L. Silverstein, M.D.
Professor and Chairman, Department of Medicine Medical College of Wisconsin
414-805-0518 [email protected]
View Bio
End of main page content.